Page last updated: 2024-08-25

tetrandrine and Laryngeal Neoplasms

tetrandrine has been researched along with Laryngeal Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Cui, X; Wang, X; Xiao, D1
Li, D; Li, Y; Wang, P; Yin, W; Zhu, W1
Cui, X; Wang, P; Wang, X; Zhu, W1

Other Studies

3 other study(ies) available for tetrandrine and Laryngeal Neoplasms

ArticleYear
Inhibition of laryngeal cancer stem cells by tetrandrine.
    Anti-cancer drugs, 2019, Volume: 30, Issue:9

    Topics: AC133 Antigen; Apoptosis; Benzylisoquinolines; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Laryngeal Neoplasms; Proto-Oncogene Proteins c-bcl-2; Signal Transduction

2019
Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells.
    The Journal of international medical research, 2020, Volume: 48, Issue:8

    Topics: Benzylisoquinolines; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; High-Temperature Requirement A Serine Peptidase 1; Humans; Laryngeal Neoplasms; RGS Proteins

2020
Tetrandrine Inhibits the Intracellular Calcium Ion Level and Upregulates the Expression of Brg1 and AHNAK in Hep-2 Cells.
    Clinical laboratory, 2015, Volume: 61, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Cell Cycle; Cell Proliferation; Cell Survival; DNA Helicases; Flow Cytometry; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Inhibitory Concentration 50; Laryngeal Neoplasms; Membrane Proteins; Neoplasm Proteins; Nuclear Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Up-Regulation

2015